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Follicular helper T (Tfh) cells are necessary for germinal center (GC) formation and within 
the GC, provide key signals to B cells for their differentiation into plasmablasts and plasma 
cells that secrete high-affinity and isotype-switched antibody (Ab). A specialized subset 
of Foxp3+ T cells termed T follicular regulatory (Tfr) cells, also regulate the differentiation 
of Ab-secreting cells from the GC. Tfr-cell function in the GC is not well understood, 
however, the dominant paradigm currently is that Tfr cells repress excessive Tfh and GC 
B cell proliferation and help promote stringent selection of high-affinity B cells. A mouse 
model where the Bcl6 gene is specifically deleted in Foxp3+ T cells (Bcl6FC mice) allows 
the study of Tfr cell function with more precision than other approaches. Studies with this 
model have shown that Tfr cells play a key role in maintaining GC B cell proliferation and 
Ab levels. Part of the mechanism for this positive “helper” effect of Tfr cells on the GC is 
Tfr cell-derived IL-10, which can promote B cell growth and entry into the dark zone of 
the GC. Recent studies on Tfr cells support a new paradigm for Tfr cell function in the 
GC reaction. Here, we review studies on Tfr cell functions and discuss the evidence that 
Tfr cells can have a major helper role in the GC-dependent Ab response.
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iNTRODUCTiON
A major function of the adaptive immune response is to produce highly specific antibodies (Abs) 
that bind to antigen (Ag) with high affinity and help to eliminate pathogens and foreign substances. 
A specialized subset of differentiated CD4 T cells, follicular helper T (Tfh) cells, are required in the 
germinal center (GC) reaction to help B cells generate high-affinity Abs to Ag (1, 2). Tfh cells control 
the initiation as well as the outcome of the GC B cell response (3–6). Tfh cells are critical for the 
proper production of protective Abs during an infection, however, the over-production of Tfh cells 
can also lead to autoimmunity since Tfh cells can help B cells to produce self-reactive Abs (6–8). 
Thus, the proper regulation of Tfh cell differentiation is essential both for normal immune function 
and for preventing autoimmune disease.
Germinal center B cell responses are also regulated by T follicular regulatory (Tfr) cells, which 
develop from regulatory T cells (Tregs) and localize to the GC (9–16) (Figure 1). Tfr cells are generally 
thought to limit the function of Tfh cells in the GC (9–13, 16). Tfr cells, like Tfh cells, are dependent 
upon the transcriptional repressor protein Bcl6 for their development, but unlike Tfh cells express 
the canonical Treg master regulatory transcription factor Foxp3 (9–16). The prevailing model for Tfr 
cell function currently is that Tfr cells repress excessive Tfh and GC B cell proliferation and promote 
the selection of high-affinity B cells (9–13, 16), however, the complete range of Tfr cell functions are 
poorly understood. A Tfr-deficient mouse model where the Bcl6 gene is specifically deleted in Foxp3+ 
T cells (Bcl6 fl/fl Foxp3-Cre or Bcl6FC mice) has been used by us and others to study Tfr cell function 
FiGURe 2 | Cell surface receptors and transcription factors involved in T follicular regulatory (Tfr) cell differentiation and function. Red receptors are downregulated 
and green receptors are upregulated during Tfr cell differentiation.
FiGURe 1 | Follicular helper T (Tfh) and T follicular regulatory (Tfr) cells both act in the germinal center (GC) to regulate the generation of antigen (Ag)-specific 
antibody-secreting cells. Tfh cells differentiate from conventional CD4 T cells after activation with Ag and dendritic cell (DC) presentation. Tfr cells differentiate  
from conventional regulatory T cells (Tregs) and migrate into the GC.
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in immune and autoimmune responses (14, 17–19). With this 
model, we and others have unexpectedly found that the major Tfr 
cell function may not be inhibiting the GC response but instead 
helping promote the Ab response and even the magnitude of the 
GC response. Here, we discuss the current understanding of the 
differentiation and physiological functions of Tfr cells. We also 
discuss how Tfr cells balance suppressive and helper functions, 
the potential mechanisms underlying Tfr cell functions, and 
directions for future investigations.
DiFFeReNTiATiON AND ReGULATiON  
OF Tfr CeLLS
Several studies have shown that Tfr cells primarily differentiate 
from Foxp3+ Treg precursor cells (10, 11, 20–22) (Figure  2), 
however, like Tfh cells, Tfr cells can also develop from naïve CD4 
T cells (23). Tregs are generated either during T cell differentia-
tion in the thymus (tTregs) or from mature CD4 T cells in the 
periphery (pTregs) (24, 25), but whether Tfr cells preferentially 
develop from tTregs or pTregs is not known. Tregs in the intesti-
nal mucosa are predominantly pTregs that develop to Ags derived 
from microbiota and diet as a tolerance mechanism (24, 25). Tfr 
cells that develop in the gut lymphoid tissues such as Peyer’s 
patches may therefore differentiate from pTregs, and so ultimately 
may have a naïve CD4 T cell origin. Interestingly, Peyer’s patch 
Tfr cells have a markedly different transcriptome than peripheral 
lymph node Tfr cells, possibly suggesting a different origin (26).
T follicular regulatory cells express Tfh cell surface markers 
such as PD-1, CXCR5, and ICOS, Treg surface markers such 
as CTLA-4 and GITR, and the master regulatory transcription 
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factors for both Tregs (Foxp3) and Tfh cells (Bcl6) (9–11, 14, 27). 
Thus, Tfr cells display a hybrid or mixed Tfh/Treg phenotype. 
Most studies have analyzed Tfr cells in the mouse, but pheno-
typically similar Tfr cells have also been described for humans 
(28, 29) and macaques (30). Tfr cells also express significant 
levels of Blimp1, a transcriptional repressor protein that sup-
presses Bcl6 expression (10, 31). Notably, Tfr cells express lower 
CD25 compared with non-Tfr Tregs (14, 29). Together with Bcl6, 
Nfat2 upregulates CXCR5 expression on Tregs and enables them 
to migrate to GC, take on the follicular phenotype and become 
Tfr cells (9–11, 14, 32). Recent work has revealed that the mTor 
pathway is a key regulator of Tfr cells. The mTorc1 complex is 
essential in regulating the conversion of Tregs to Tfr cells and 
this is potentially through a Stat3–Tcf-1–Bcl6 pathway (33, 34). 
Our lab has also specifically found that in contrast to Tfh cells 
which can develop in the absence of Stat3, Stat3 is essential for 
Tfr cell development (15). Deletion of Pten in Tregs leads to 
upregulated mTorc2 activity and heightened Tfr cell develop-
ment (35). Thus, the Akt–mTor2 kinase pathway promotes Tfr 
cell development and the Pten phosphatase helps restrain exces-
sive Tfr cell development (35).
Antigen exposure triggers the differentiation of Tfr cells and 
this process is dendritic cell (DC)-dependent (10, 11, 23, 27). Sage 
et  al. used mice that express diphtheria toxin receptor specifi-
cally on DCs to test this (12). DC-depletion led to substantially 
decreased Tfr cells, however, it is unknown which specific DC 
subsets directly contribute to Tfr cell differentiation. At the same 
time, PD-1-ligand expressed on DCs has an inhibitory role on 
Tfr cell development (36). Tregs can repress the function of Ag 
presenting cells (APCs) including DCs (37), but whether Tfr cells 
can affect DCs or other APCs and how this might affect the GC 
response is unknown. Precisely what Ags and signals that Tregs 
respond to in order to become Tfr cells is not well understood. 
Tfr cells respond more strongly to self-Ags than foreign Ags, 
which fits with the self-reactive nature of tTregs (23, 38). While 
Tfr cells can be found that have specificity for the immunizing 
Ag (23), a recent study on the TCR specificity of Tfh and Tfr cells 
indicated that in contrast to Tfh cells, Tfr cells do not respond 
well to the cognate Ag after immunization (22). Furthermore, an 
analysis of TCR gene sequences in Tfh and Tfr cells indicated 
that Tfh cells are a sub-population of cells related to naïve CD4 
T cells, whereas Tfr cells showed a TCR profile very similar to 
the total Treg population (22). These findings are consistent with 
the model that Tfh cells are Ag-specific T cells that proliferated 
after Ag stimulation, while Tfr cells develop in a polyclonal and 
Ag-independent manner from Tregs. Therefore, Tfr cells either 
develop from Tregs in a polyclonal TCR-dependent response 
involving recognition of self-Ag, or Tfr cells expand and dif-
ferentiate by an Ag-independent and TCR independent pathway 
[e.g., Jagged1 plus Ox40 stimulation (39)]. Note that the Maceiras 
et al. study (22) of Tfr cell TCR sequences analyzed Tfr cells from 
peripheral LNs, and the TCR specificity of Peyer’s patch Tfr cells 
may be more similar to naïve CD4 T cells that are responsive to 
gut Ags.
T cell co-stimulation is required for Tfr cell differentiation as 
either CD28 or ICOS deficiency leads to reduction of Tfr cells 
(10, 27, 40). Mice with CD28 deficiency specifically in Tregs 
(using Foxp3-cre) had a large reduction in Tfr cells in the drain-
ing lymph node after NP-OVA immunization (40). This is largely 
due to the roles of CD28 in inducing Foxp3 expression as well 
as Tfr cell proliferation (10, 41–44). Similarly, Tfr cell develop-
ment is abrogated in ICOS-deficient mice (27). ICOS signaling 
modulates the expression of Bcl6 and c-Maf in Tfh cells and 
might play a similar role in Tfr cells (45–47). Bcl6 is an essential 
transcription factor for Tfr cells, and recent studies suggest 
that c-Maf is also pivotal for Tfr cell differentiation (10, 11, 14, 
48, 49). Bcl6 and Blimp1 reciprocally repress expression of the 
other factor in both Tfh and Tfr cells (31, 50). The regulation 
of Tfh cell differentiation by Blimp1 is Bcl6-dependent while 
Blimp1 controls Tfr cell differentiation independent of Bcl6 (31). 
One mechanism for Bcl6-independent Blimp1 activity may relate 
to regulation of Nfat2, which has been shown to be impor tant 
for upregulation of CXCR5 on Tfr cells as well as for expres-
sion of PD-1 (32, 51). Blimp1 has been shown to repress Nfat2 
expression (51), and thus Blimp1 could have a suppressive role 
for CXCR5 and PD-1, both of which are key genes increased 
in Tfr cells. Increased expression of Nfat2 in Blimp1-deficient 
Tregs could then lead to Bcl6-independent expression of CXCR5 
and PD-1, and appearance of Tfr-like cells (31). Tfr cells were 
repressed by high IL-2 levels at the peak of influenza infection 
and this was through a Blimp1-dependent mechanism (19). IL-2 
is also a negative signal for Bcl6 expression, and decreased IL-2 
promotes induction of Tfr cells. After the peak anti-flu virus 
immune response, CD25 expression is downregulated in some 
Tregs while Bcl6 is increased, leading to Tfr programming (19). 
Thus, IL-2 is a key factor regulating Tfr differentiation, promot-
ing Blimp1 expression while repressing Bcl6 in Tregs to preclude 
Tfr cell development.
PD-1, which is expressed by both Tfh and Tfr cells, inhibits 
Tfr differentiation and their suppressive function (10, 11, 
16, 27). Sage et al. showed that Tfr cells in Pdcd1-deficient mice 
had greater suppressive function and resulted in decreased Ab 
production both in vitro and in vivo (27). The exact mechanism 
for the increased inhibitory function of Pdcd1-deficient Tfr cells 
remains unclear. At the same time, PD-1 ligand is required for Tfr 
cell generation, however, it is not clear if this is a direct or indirect 
effect on Tfr cells (23). Similarly, CTLA-4, the inhibitory receptor 
which binds to CD80 and CD86, limits the differentiation of Tfr 
cells (13, 52, 53). However, restricted CTLA-4 deficiency in Tregs 
contributes not only to enhanced Tfr cells but also enhanced Tfh, 
GCB  cells, and Ab responses (53). One explanation is that in 
the absence of CTLA-4 function in Tregs, there is uncontrolled 
inflammation that drives higher Tfh cell and GCB responses. 
However, since it is not clear what drives the enhanced Tfh, GCB, 
and IgE responses, a “helper” role of Tfr cells cannot be com-
pletely excluded (53). Deletion of CTLA-4 results in increased 
IL-10 production by Tregs (54). Since IL-10 can promote GC 
responses (17, 55), it is possible that increased IL-10 production 
by Tfr cells contributes to the increased GC and Ab response in 
CTLA-4 KO mice.
The majority of research on Tfr cells has been conducted in 
the mouse system but a few recent studies have elucidated Tfr 
cell populations in human GCs that are basically similar to Tfr 
cells in mice (29, 56, 57). CXCR5+ Tfh-like cells in blood, also 
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known as circulating Tfh (cTfh) cells, are typically used as a proxy 
marker for the GC Tfh cell response in humans. By assessing cTfh 
cell frequency in patients with monogenic mutations leading to 
immunodeficiency, a large number of genes controlling human 
Tfh cell development have been categorized (58). Circulating 
Tfr (cTfr) cells in blood are also used as a correlate of the Tfr 
cell response (28, 59–62), however, in contrast to Tfh cells (58), 
relatively few genes that control Tfr cell development and func-
tion in humans have been characterized to date (e.g., LRBA and 
CTLA4) (62–64). Thus, much work remains in fully understand-
ing specific genes and pathways that regulate human Tfr cells.
SUPPReSSive FUNCTiONS OF Tfr CeLLS
T follicular regulatory cells have been described in the literature 
mainly as suppressors of the GC reaction and the Ab response, 
repressing the proliferation of Tfh cells and GC B  cells, and 
limiting the generation of Ab-secreting cells and overall Ab 
responses. However, the experimental approaches taken in many 
studies can give rise to alternative interpretations. In vitro, Tfr 
cells can suppress the proliferation and cytokine production of 
Tfh cells as well as the proliferation and Ig secretion of B cells, 
similar to the in  vitro suppressive function seen with non-Tfr 
Tregs (13, 27–29, 38, 65). In vivo studies have demonstrated 
that Tfr cells, analyzed initially by depletion of total Tregs, can 
suppress the numbers of GC B  cells and Tfh cells (9–11, 13, 
27, 53). However, these studies may not represent specific effects 
of Tfr cell depletion or physiological Tfr cell function. Total 
Treg deletion (10, 11, 13, 66) provokes severe inflammation and 
causes a very broad effect on T cell responses, thus obscuring the 
specific functions of Tfr cells. Studies using adoptive transfer of 
Tfr cells along with other T cells into T cell-deficient mice or Tfh- 
cell-deficient mice might have non-physiological effects due to 
the abnormal immune environment of the recipient mice (10, 11, 
27, 33). Studies where Tfr cell numbers are greatly enhanced due 
to deletion of Roquin (34), or where Tregs are forced to migrate 
to the B  cell follicle by ectopic CXCR5 expression (32) might 
also lead to non-physiological suppression and/or non-specific 
suppression of GC responses. Mice with the Nfat2 gene deleted 
in Tregs with Foxp3-cre showed a partial loss of Tfr cells and 
augmented numbers of GC B  cells, Tfh cells, and Ag-specific 
Abs after immunization (32). However, a more general loss 
of Treg function by loss of Nfat2 affecting Tfh cell expansion 
cannot be discriminated from the specific effects from loss of 
Tfr cells. In vitro studies of Tfr cells cannot mimic the complex 
in vivo environment of the GC reaction and cannot analyze affin-
ity selection of GC B cells. Together, a re-interpretation of the 
Tfr cell literature helps to explain why the function of Tfr cells 
assessed using Bcl6FC mice (14, 17, 19), is strikingly different 
from many other studies on Tfr cell function.
Nonetheless, it is clear that under some conditions, Tfr cells 
can negatively regulate the GC reaction, and the precise mecha-
nisms that Tfr cells use to negatively regulate the GC is one of 
the unsolved mysteries in the Tfr cell field. Tregs can suppress 
immune responses by multiple known mechanisms: IL-2 con-
sumption, secretion of inhibitory factors (IL-10, TGF-β, IL-35, 
granzyme B, CD39, CD73, and TRAIL), and CTLA-4-mediated 
inhibition of Tfh cell co-stimulation (67–69). Of these known 
suppressor factors, we can narrow down mechanisms for Tfr cells 
based on previous data. Tfh cell differentiation is inhibited by IL-2 
(70–72), and IL-2 consumption by Tfr cells could be predicted to 
help stabilize Tfh cell responses. However, Tfr cells have low levels 
of the high-affinity IL-2 receptor CD25 (14), which indicates a 
lessened capacity to compete for available IL-2. IL-10 is unlikely 
to be the key suppressor factor, since IL-10 is a stimulatory or 
growth factor for GC B cells (17), and furthermore, IL-10 expres-
sion by Tfh cells is increased in the absence of Tfr cells in Bcl6 mice 
(14). IL-35 is unlikely to be a Tfr suppressor factor as it primarily 
affects T cell proliferation (73), and data with Bcl6FC mice does 
not indicate an effect of Tfr cells on the number of Tfh cells (14). 
Granzyme B is unlikely as a major mechanism as it is decreased in 
Tfr cells compared to Tregs (10). Metabolic suppressor pathways 
such as CD39 and CD73 have not been extensively characterized 
and are possible effectors of suppression by Tfr cells as they could 
potentially affect cell proliferation in the GC. In mice, TGF-β is 
known to stabilize Tfh cell responses (74), and prevent excess Tfh 
cell responses (75). In humans, TGF-β is required for Tfh cell 
differentiation (76). A lack of TGF-β signaling from loss of Tfr 
cells does not clearly explain the normal Tfh cell numbers in the 
presence of increased Tfh cytokine expression in Bcl6FC mice 
(14). TRAIL is cytotoxic to follicular B cell lymphomas, which 
have a GC phenotype (77), but otherwise there is no data about 
TRAIL activity in GCs, particularly regarding Tfr cells. CTLA-4 
expression by Tfr cells may inhibit the ability of Tfh cells to receive 
key co-stimulation signals from GC B cells, thus limiting Tfh cell 
and thus Tfh cell-driven GC B  cell expansion. Unfortunately, 
studies on the role of CTLA-4 function in Tfr cells are difficult to 
interpret, as noted above (13, 52, 53).
A recently described mechanism for Tfr cells to inhibit Tfh cells 
and the GC is secretion of a decoy IL-1 receptor that inhibits Tfh 
cell differentiation (38). This pathway appears to be most critical 
during early Tfh cell activation and differentiation rather than 
during the GC reaction itself. Furthermore, data pointing to this 
decoy IL-1 receptor pathway being used specifically by Tfr cells 
to control Tfh cells in vivo is lacking. Another potential pathway 
used by Tfr cells to control Tfh cells and GC B cells is the inhibi-
tory receptor TIGIT, that is important for Treg suppressive func-
tion (14, 78). Intriguingly, the two major suppressive pathways 
utilized by TIGIThigh Tregs are IL-10 and Fibrinogen-like protein 
2 (Fgl2) (78). Fgl2 is a secreted protein that binds the inhibitory 
IgG receptor FcγRIIB (79). As noted above, it is unlikely that loss 
of IL-10 from Tfr cells contributes to the deregulated cytokine 
expression of Tfh cells. Thus, Fgl2 may be a key factor used by 
Tfr cells to regulate GC B cells. Interestingly, FcγRIIB KO mice 
are known to develop lupus (80), and Fgl2 KO mice develop 
glomerulonephritis, a pathologic manifestation of auto-Abs in 
severe lupus disease also seen in IgA nephropathy (81, 82). Fgl2 
KO mice have Treg defects, but the GC response in these mice 
has not been characterized (81). TIGIThigh Tregs can also affect 
cell activation by inducing tolerogenic DCs via CD155 (83). But 
currently, data showing Tfr cells controlling the GC via TIGIT is 
lacking.
In analyzing mice with deletions of Bcl6 or Stat3 specifically 
in the Treg lineage (Bcl6FC and Stat3FC mice, respectively), we 
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found noteworthy differences between how Tfr cells are regulated 
by Stat3 and Bcl6 (14, 15). While Tfr cells are strongly depleted 
in both Bcl6FC and Stat3FC mice (14, 15), there are significant 
differences in the phenotype. First, in Bcl6FC but not Stat3FC 
mice, Tfh cells produce higher levels of cytokines compared to 
control mice. Second, Ag-specific IgA is increased in Bcl6FC mice 
whereas Ag-specific IgG is increased in Stat3FC mice (14, 15). 
At the same time, Tfh cell and GC B cell numbers are not altered in 
either Bcl6FC or Stat3FC mice compared to control mice (14, 15). 
The function of Stat3 in Tfr cells is not understood. Analogous to 
Tfh cells (84, 85), Stat3 may be important for Tfr cell development 
by inducing Bcl6 expression in Tregs in response to cytokines 
such as IL-6 and IL-21. Stat3 expression is also activated in Tfr 
cells by the mTorc1 pathway (33). Bcl6 is required for the develop-
ment of the CXCR5+PD-1+ follicular T cell phenotype, and the 
induction of Bcl6 by STAT factors may be essential for both Tfr 
cell as well as Tfh cell development. If this is the case though, 
why does deletion of Stat3 in Foxp3-expressing cells produce a 
different phenotype than deletion of Bcl6 in Foxp3-expressing 
cells? Why are cytokines upregulated from Tfh cells in Bcl6FC 
mice but not in Stat3FC mice? The answer to this question is 
currently unknown but is essential for fully understanding Tfr 
cell development and function. One possible explanation for the 
difference is that there is a larger population of residual Tfr cells 
in Stat3FC mice compared to Bcl6FC mice and these residual 
Tfr cells in Stat3FC mice are enough to negatively regulate Tfh 
cells. Thus, there is a greater deletion of Tfr cells in Bcl6FC mice, 
leading to a more complete loss of repression by Tfr cells, and 
thus increased Tfh cell activity. The increased Tfh cell cytokines in 
Bcl6FC mice might promote the elevated IgA response that is not 
seen in Stat3FC mice. In summary, in the Bcl6FC model, Tfr cells 
repress Tfh cell activity but not proliferation. Why Ag-specific IgG 
is increased in Stat3FC mice is unclear, but possibly the residual 
Tfr cells in Stat3FC mice have augmented GC helper activity.
T follicular regulatory cells have been studied extensively in 
immune responses induced by model protein Ags and adjuvants. 
Studies on Tfr cell function in regulating the gut microbiota (86) 
or in viral infection (17–19) have also been performed. More than 
the type of immune challenge, the model system used to assess 
Tfr cell function (e.g., Treg depletion in mice versus Bcl6FC mice) 
determines whether suppression by Tfr cells is observed.
ROLe OF Tfr CeLLS iN AUTOiMMUNe 
DiSeASe
An important area where Tfr cells have a clear suppressive effect 
on the GC and Ab response, even in Bcl6FC mice, is in sup-
pression of auto-Abs that drive autoimmune disease (14, 18, 19, 
32, 40). This role of Tfr cells in suppressing auto-Ab production 
was elucidated most thoroughly by Fu et al. who showed that 
Bcl6FC mice developed late-onset Sjogren’s-like autoimmune 
disease and autoimmunity could be induced in young mice by 
immunizing mice with salivary gland extracts (18). The precise 
mechanisms for how Tfr cells can suppress auto-Abs while at 
the same time promote the Ab response to foreign Ags remains 
unexplored. One possible explanation is that since Tfr cells, like 
Tregs, have a bias toward self-Ag recognition (22, 23, 38), they 
are able to inhibit self-reactive Tfh cells that might develop in 
the GC by competing with them for recognition of self-Ags on 
GC B cells and binding and blocking B7 co-stimulatory recep-
tors via CTLA-4. Little is known about the role of Tfr cells in 
human autoimmune disease, but increased levels of cTfr cells 
are observed in patients with Sjogren’s disease (28, 59) and 
systemic lupus erythematosus (60). Interestingly, an increased 
ratio of cTfr to cTfh cells is strongly associated with more severe 
disease in the case of Sjogren’s syndrome (59). Whether high 
levels of cTfr cells simply represent the presence of active GC 
responses or whether cTfr cells are especially elevated in autoim-
mune disease is not clear. The data with Sjogren’s cTfr cells is 
particularly hard to interpret since the cells have an immature 
CD25+ Tfr phenotype and their relationship to GC-localized Tfr 
cells is unclear (59).
“HeLPeR” FUNCTiONS OF Tfr CeLLS
Although Tregs themselves are overwhelmingly described as sup-
pressor cells, there are several reports that Tregs can promote 
immune responses in certain circumstances. Under inflamma-
tory conditions or in mice with mutations in genes that affect 
Foxp3 expression, a fraction of Tregs can become “ex-Tregs” and 
differentiate into proinflammatory cells (87, 88). Surprisingly, ex-
Tregs can also convert into functional Tfh cells in Peyer’s patches 
(89) and in atherosclerosis (90).
The first published characterization of Tfr cells in 2009 by 
Linterman et al. showed that Tfr cells had a key “helper” role in 
terms of helping Tfh cells select high-affinity Ag-specific B cell 
clones (7). In their proposed model, Tfr cells restrict the out-
growth of non-Ag-specific B cell clones in the GC, presumably 
allowing for more efficient interaction of Tfh cells with selection 
of specific high-affinity Abs (7). At the same time, the Linterman 
et al. data can also be interpreted as showing evidence for a major 
helper function for Tfr cells in the GC. For instance, a significant 
decrease in Ag-specific GC B  cells is observed after total Treg 
depletion at the same time that total GC B  cells increased (7). 
This can be interpreted as two distinct processes: (1) loss of Tfr 
cells leads to a loss of Tfr cell helper activity and thus reduced 
Ag-specific GC B cells and (2) because total Tregs are depleted, 
there is a massive increase in GC responses to commensals and 
self-Ags—responses that are normally inhibited by Tregs. Even 
though these latter commensal-specific and self-Ag-specific 
GCs may be weakened by loss of Tfr cell helper activity, the large 
number of these responses leads to a total increase in GC B cells.
A different Treg–Tfh helper pathway was shown by Leon et al., 
who found that Tregs are required for the normal anti-influenza 
Tfh cell response (66). In this study, ex-Tregs were not convert-
ing into Tfh cells, and Leon et al. proposed a mechanism where 
CD25+ Tregs take up IL-2 and limit the overall availability of 
IL-2, thereby promoting Tfh cell differentiation (66). Importantly, 
however, Leon et al. did not investigate loss of Tfr cells (which 
would occur with Treg depletion) as a mechanism for the Treg 
helper effect, and their data does not eliminate a helper role for 
Tfr cells in the Tfh/GC response in the virus infection system.
Because of the problems associated with deleting total Tregs 
and the lack of specific and robust models to deplete Tfr cells 
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in vivo, we developed Bcl6FC mice (14). In these mice, Tfr cell 
development is specifically blocked without a loss in total Tregs 
or Treg function (14). We determined that loss of Tfr cells led 
to a significantly decreased IgG response and that Tfr cells were 
required to produce the highest affinity Ag-specific Abs (14). 
These results are consistent with a critical helper role for Tfr cells 
in the GC. In our published results, we did not observe a loss 
of GC B cells or Tfh cells in Bcl6FC mice despite the decreased 
IgG response (14). This could be due to the time-point where we 
analyzed the GC or the type of Ag used to induce the GC.
In 2017, Laidlaw et al. presented the clearest evidence to date 
that Tfr cells can act as essential helper cells in the GC (17). In 
this study, mice were infected with lymphocytic choriomenin-
igitis virus (LCMV) and the GC and Ab response analyzed (17). 
Importantly, Laidlaw et al. used Bcl6FC mice and Treg-specific 
IL-10 cKO mice to demonstrate that Tfr cells are a critical source 
of IL-10 in the GC and that IL-10 drives the growth of GCs by 
promoting entry of GC B  cells into the dark zone (17). In the 
absence of IL-10-producing Tfr cells, GC B cell numbers and the 
LCMV-specific Ab response were decreased (17). A recent study 
with malaria infection in mice also showed that IL-10 was criti-
cal for the maintenance of the GC and GC-derived Ab response 
(55). Overall, these recent findings strongly support the idea that 
IL-10-producing Tfr cells have a major role in maintaining the 
GC reaction and thus act as “helper cells.” In our lab, we have 
been using Bcl6FC mice and analyzing the role of Tfr cells in a 
food allergy model with peanut Ag. In this model, we find that 
Tfr cells help maintain the peanut-specific GC response and IgE 
response (Markus M. Xie and Alexander L. Dent, manuscript in 
preparation). Tfr cells thus appear to have a key role in allergic 
immune responses, and represent a novel target for allergy-
specific immunotherapy.
OUTSTANDiNG QUeSTiONS AND FUTURe 
DiReCTiONS
As of this writing, Tfr cells have only been analyzed in a very small 
fraction of infectious disease models and immunological diseases 
such as allergy and autoimmunity. Testing Tfr cell function in 
various disease states will be an important area for future research 
on Tfr cells. Also unknown is if Tfr cells affect diseases that are 
not driven by Ab-mediated pathology. Whether Tfr cells play a 
regulatory role in cancer, diabetes, heart disease, atherosclerosis, 
or other types of inflammatory diseases, is ripe for exploration. 
The mechanism of Tfr cell help in the GC is not completely under-
stood and an important topic is why some types of GC responses 
seem to rely on Tfr cells for help whereas other GC responses 
are only mildly affected or not affected at all by loss of Tfr cells. 
A major issue for future studies is whether Tfr cells switch between 
help and suppression in the GC for foreign Ag, or primarily 
FiGURe 3 | T follicular regulatory (Tfr) cells play a dual role in the germinal center reaction. Tfr cells can suppress the activation of follicular helper T (Tfh) cells, in part 
by CTLA-4-mediated inhibition of co-stimulation. However, Tfr cells also play a major role in helping promote germinal center B cell proliferation, by producing IL-10.
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CONCLUSiON
Even though Tregs act overwhelmingly as major suppressors of 
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